As the COVID-19 pandemic begins to rear its head again in the wake of reopenings in the U.S., accelerating the research pipeline for treatments and vaccines becomes more important than ever. Now, the National Institutes of Health (NIH) is launching a massive COVID-19 patient data store and analytics platform to help researchers understand the disease and develop effective treatments.
The centralized data store is part of a new effort called the National COVID Cohort Collaborative (N3C), which is operated under the NIH’s National Center for Advancing Translational Sciences (NCATS). The data store – called the NCATS N3C Data Enclave – will “systematically collect clinical, laboratory, and diagnostic data from healthcare provider organizations worldwide.” So far, this includes 35 collaborating sites across the country.
The analytics component of the enclave will convert all of the data into a standard format, allowing it to be shared with researchers and healthcare providers around the world – regardless of whether or not they contribute data themselves. In order to comply with health data privacy laws like HIPAA, the data will only retain two identifyin...
Note: If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).